Pharmacokinetics of Dantrolene in the Plasma Exchange Treatment of Malignant Hyperthermia in a 14-Year-Old Chinese Boy: A Case Report and Literature Review
Malignant hyperthermia (MH) is a rare life-threatening response that is triggered by exposure to specific anesthetics commonly used during surgical interventions. Dantrolene is a well-known drug used as the first-line therapy for MH. A 14-year-old Chinese boy with a mutation in type 1 Ryanodine rece...
Main Authors: | Xiaoxiao Li, Chao Li, Yang Zhou, Zhengqian Li, Xin Xiong, Chuhui Wang, Congya Zhou, Bin Han, Li Yang, Xiangyang Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.918245/full |
Similar Items
-
Malignant hyperthermia when dantrolene is not readily available
by: Xiaodan Gong
Published: (2021-04-01) -
The Anesthesiologists’ Perception of Malignant Hyperthermia and Availability of Dantrolene in China: A Cross-Sectional Survey
by: Wang J, et al.
Published: (2024-03-01) -
Malignant hyperthermia in India: Time for awakening, useful facts on Dantrolene
by: Viji S. Pillai, et al.
Published: (2015-01-01) -
Malignant hyperthermia in children
by: Igrutinović Zoran, et al.
Published: (2008-01-01) -
Malignant hyperthermia: current approaches to prevention and treatment
by: E. S. Kim, et al.
Published: (2017-09-01)